Tae-Kwang Kim, Jeong-Eun Lee, Kyuho Jeong, Min-Jun Baek, Dahan Kim, Jun-Young Jeon, Sangyoung Lee, Dae-Duk Kim
{"title":"针对高血压和血脂异常患者的缬沙坦、氨氯地平、罗伐他汀和依折麦布固定剂量复方片剂的战略设计和临床评估","authors":"Tae-Kwang Kim, Jeong-Eun Lee, Kyuho Jeong, Min-Jun Baek, Dahan Kim, Jun-Young Jeon, Sangyoung Lee, Dae-Duk Kim","doi":"10.1007/s40005-023-00651-w","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"122 49","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Strategic design and clinical evaluation of a fixed-dose combination tablet comprising valsartan, amlodipine, rosuvastatin and ezetimibe for patients with hypertension and dyslipidemia\",\"authors\":\"Tae-Kwang Kim, Jeong-Eun Lee, Kyuho Jeong, Min-Jun Baek, Dahan Kim, Jun-Young Jeon, Sangyoung Lee, Dae-Duk Kim\",\"doi\":\"10.1007/s40005-023-00651-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":16702,\"journal\":{\"name\":\"Journal of Pharmaceutical Investigation\",\"volume\":\"122 49\",\"pages\":\"\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2023-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40005-023-00651-w\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40005-023-00651-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Strategic design and clinical evaluation of a fixed-dose combination tablet comprising valsartan, amlodipine, rosuvastatin and ezetimibe for patients with hypertension and dyslipidemia
期刊介绍:
Journal of Pharmaceutical Investigation(J. Pharm. Investig.), the official journal of the Korean Society of Pharmaceutical Sciences and Technology, is an international, peer-reviewed journal that covers all pharmaceutical sciences, including engineering, regulatory, physicochemical, biological, and microbiological studies related to the conception, design, production, characterization and evaluation of pharmaceutical products and drug delivery systems. It is a bimonthly journal published in January, March, May, July, September, and November. All manuscript should be creative and informative for pharmaceutical scientists, and should contain advanced knowledge in clear and concise English. Articles in the following categories are published: Research articles, Notes, Information, and Reviews.(Formerly Journal of Korean Pharmaceutical Sciences: ISSN 0259-2347)